125 related articles for article (PubMed ID: 10191190)
1. Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo.
Oldstone MB; von Herrath M; Lewicki H; Hudrisier D; Whitton JL; Gairin JE
Virology; 1999 Apr; 256(2):246-57. PubMed ID: 10191190
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
[TBL] [Abstract][Full Text] [Related]
5. CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
[TBL] [Abstract][Full Text] [Related]
6. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
7. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective cytotoxic T cells with viral proteins.
Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
[TBL] [Abstract][Full Text] [Related]
10. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
[TBL] [Abstract][Full Text] [Related]
11. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
Klavinskis LS; Tishon A; Oldstone MB
J Immunol; 1989 Sep; 143(6):2013-6. PubMed ID: 2476492
[TBL] [Abstract][Full Text] [Related]
12. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
Cook JR; Solheim JC; Connolly JM; Hansen TH
J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
[TBL] [Abstract][Full Text] [Related]
13. Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells.
Hahn K; DeBiasio R; Tishon A; Lewicki H; Gairin JE; LaRocca G; Taylor DL; Oldstone M
Virology; 1994 Jun; 201(2):330-40. PubMed ID: 8184542
[TBL] [Abstract][Full Text] [Related]
14. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
[TBL] [Abstract][Full Text] [Related]
15. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
[TBL] [Abstract][Full Text] [Related]
16. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice.
Moskophidis D; Lechner F; Hengartner H; Zinkernagel RM
J Immunol; 1994 May; 152(10):4976-83. PubMed ID: 8176216
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.
Hudrisier D; Riond J; Gairin JE
J Virol; 2001 Mar; 75(5):2468-71. PubMed ID: 11160751
[TBL] [Abstract][Full Text] [Related]
18. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
Rötzschke O; Falk K; Deres K; Schild H; Norda M; Metzger J; Jung G; Rammensee HG
Nature; 1990 Nov; 348(6298):252-4. PubMed ID: 1700304
[TBL] [Abstract][Full Text] [Related]
19. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
Rall GF; Mucke L; Oldstone MB
J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
[TBL] [Abstract][Full Text] [Related]
20. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
Klenerman P; Zinkernagel RM
Nature; 1998 Jul; 394(6692):482-5. PubMed ID: 9697771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
